We assessed the performance of 6-[(18)F]-fluoro-L-3,4-dihydroxyphenylalanine (F-DOPA) PET for differentiating radionecrosis (RN) from tumour progression (PD) in a population of patients with brain metastases, treated with stereotactic radiosurgery. The accuracy of F-DOPA PET was compared with that of perfusion-weighted magnetic resonance (perfusion-MR).In 42 patients with a total of 50 brain metastases from various primaries F-DOPA PET/CT was performed because of suspected radiological progression at the site of previously irradiated brain metastasis. Several semiquantitative PET parameters were recorded, and their diagnostic accuracy was compared by receiver operating characteristic curve analyses. The diagnosis was established by either surgery or follow-up. A comparison was made between F-DOPA PET and perfusion-MR sequences acquired no more than 3 weeks apart.Definitive outcome was available in 46 of the 50 lesions (20 PD, 26 RN). Of the 46 lesions, 11 were surgically excised while in the remaining 35 lesions the diagnosis was established by radiological and clinical criteria. The best diagnostic performance was obtained using the semiquantitative PET parameter maximum lesion to maximum background uptake ratio (SUVLmax/Bkgrmax). With a cut-off value of 1.59, a sensitivity of 90 \% and a specificity of 92.3 \% were achieved in differentiating RN from PD lesions (accuracy 91.3 \%). Relative cerebral blood volume (rCBV) derived from perfusion-MR was available for comparison in 37 of the 46 metastases. Overall accuracy of rCBV was lower than that of all semiquantitative PET parameters under study. The best differentiating rCBV cut-off value was 2.14; this yielded a sensitivity of 86.7 \% and a specificity of 68.2 \% (accuracy 75.6 \%).F-DOPA PET is a highly accurate tool for differentiating RN from PD brain metastases after stereotactic radiosurgery. In this specific setting, F-DOPA PET seems to perform better than perfusion-MR.

Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery / Cicone, Francesco; Romano, Andrea; Scaringi, Claudia; Bozzao, Alessandro; MAURIZI ENRICI, Riccardo; Scopinaro, Francesco; Minniti, Giuseppe; Papa, Annalisa; Tavanti, Francesca. - In: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. - ISSN 1619-7070. - 42:1(2014), pp. 103-111. [10.1007/s00259-014-2886-4]

Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery.

CICONE, FRANCESCO;ROMANO, Andrea;SCARINGI, CLAUDIA;BOZZAO, ALESSANDRO;MAURIZI ENRICI, Riccardo;SCOPINARO, Francesco;MINNITI, GIUSEPPE;PAPA, ANNALISA;TAVANTI, FRANCESCA
2014

Abstract

We assessed the performance of 6-[(18)F]-fluoro-L-3,4-dihydroxyphenylalanine (F-DOPA) PET for differentiating radionecrosis (RN) from tumour progression (PD) in a population of patients with brain metastases, treated with stereotactic radiosurgery. The accuracy of F-DOPA PET was compared with that of perfusion-weighted magnetic resonance (perfusion-MR).In 42 patients with a total of 50 brain metastases from various primaries F-DOPA PET/CT was performed because of suspected radiological progression at the site of previously irradiated brain metastasis. Several semiquantitative PET parameters were recorded, and their diagnostic accuracy was compared by receiver operating characteristic curve analyses. The diagnosis was established by either surgery or follow-up. A comparison was made between F-DOPA PET and perfusion-MR sequences acquired no more than 3 weeks apart.Definitive outcome was available in 46 of the 50 lesions (20 PD, 26 RN). Of the 46 lesions, 11 were surgically excised while in the remaining 35 lesions the diagnosis was established by radiological and clinical criteria. The best diagnostic performance was obtained using the semiquantitative PET parameter maximum lesion to maximum background uptake ratio (SUVLmax/Bkgrmax). With a cut-off value of 1.59, a sensitivity of 90 \% and a specificity of 92.3 \% were achieved in differentiating RN from PD lesions (accuracy 91.3 \%). Relative cerebral blood volume (rCBV) derived from perfusion-MR was available for comparison in 37 of the 46 metastases. Overall accuracy of rCBV was lower than that of all semiquantitative PET parameters under study. The best differentiating rCBV cut-off value was 2.14; this yielded a sensitivity of 86.7 \% and a specificity of 68.2 \% (accuracy 75.6 \%).F-DOPA PET is a highly accurate tool for differentiating RN from PD brain metastases after stereotactic radiosurgery. In this specific setting, F-DOPA PET seems to perform better than perfusion-MR.
2014
Amino-acid PET; Brain metastases; Brain radionecrosis; DOPA; Perfusion-weighted magnetic resonance; Stereotactic radiosurgery; Adult; Aged; Aged, 80 and over; Brain Neoplasms; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Multimodal Imaging; Necrosis; Postoperative Period; Radiation Injuries; Radiosurgery; Sensitivity and Specificity; Tomography, X-Ray Computed; Magnetic Resonance Angiography; Positron-Emission Tomography; Radiopharmaceuticals; Radiology, Nuclear Medicine and Imaging; Medicine (all)
01 Pubblicazione su rivista::01a Articolo in rivista
Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery / Cicone, Francesco; Romano, Andrea; Scaringi, Claudia; Bozzao, Alessandro; MAURIZI ENRICI, Riccardo; Scopinaro, Francesco; Minniti, Giuseppe; Papa, Annalisa; Tavanti, Francesca. - In: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. - ISSN 1619-7070. - 42:1(2014), pp. 103-111. [10.1007/s00259-014-2886-4]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/779515
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 59
  • Scopus 112
  • ???jsp.display-item.citation.isi??? 106
social impact